Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Acne Medicine Market to Reach USD 4.27 Billion by 2029 | Key Trends in OTC & Prescription Segments Revealed | Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

23 May, 2025, 15:00 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India , May 23, 2025 /PRNewswire/ -- Acne Medicine Market is Segmented by Type (OTC, Prescription Medicine), by Application (Topical, Oral).

The Global Acne Medicine revenue was USD 3616.6 Million in 2022 and is forecast to a readjusted size of USD 4273.4 Million by 2029 with a CAGR of 3.4% during the review period (2023-2029).

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-13R16186/Global_and_India_Acne_Medicine_Market

Major Factors Driving the Growth of Acne Medicine Market:

The acne medicine market is experiencing significant growth propelled by rising acne prevalence, evolving skincare routines, and the growing demand for effective, accessible treatments. With options ranging from over-the-counter products to prescription solutions, the market caters to a broad consumer base. Continuous innovation, influencer marketing, and the expansion of telehealth services are reshaping how consumers approach acne management. Moreover, increasing interest in natural formulations and dermatologically tested products is redefining consumer preferences. As dermatology services become more accessible and digital platforms democratize skincare advice, the acne medicine market is expected to witness sustained growth, particularly across urban, youth-centric, and emerging economies.

Unlock Insights: View Full Report Now! https://reports.valuates.com/market-reports/QYRE-Auto-13R16186/global-and-india-acne-medicine

TRENDS INFLUENCING THE GROWTH OF THE ACNE MEDICINE MARKET:

Prescription medicines play a crucial role in driving the growth of the acne medicine market due to their high efficacy in treating moderate to severe acne. Dermatologists often prescribe topical retinoids, oral antibiotics, or isotretinoin for patients who do not respond to over-the-counter treatments. The increasing awareness among patients regarding the benefits of dermatologist-prescribed treatments has contributed to growing demand. Moreover, insurance coverage in several developed markets encourages patients to opt for prescription medications. The expanding teenage and young adult population suffering from persistent acne has also led to a surge in dermatological consultations, boosting prescription volumes. In addition, innovations in formulation and fewer side effects in newer drugs are enhancing consumer confidence, further accelerating market growth.

Over-the-counter (OTC) acne medications significantly contribute to the expansion of the acne medicine market by providing accessible and affordable solutions. Consumers prefer OTC products due to the convenience of purchase without a prescription and the availability of a wide range of options including gels, creams, face washes, and patches. Ingredients such as benzoyl peroxide, salicylic acid, and alpha hydroxy acids are commonly found in OTC products, offering effective treatment for mild to moderate acne. The rise of e-commerce platforms has made OTC acne solutions easily available to consumers globally, boosting sales. Additionally, aggressive marketing strategies and endorsements from influencers and dermatologists have elevated product visibility, encouraging higher consumer adoption and fueling market growth.

Oral acne medications are propelling market growth due to their effectiveness in treating severe and persistent acne conditions. These include oral antibiotics, hormonal treatments, and isotretinoin, which target internal root causes such as bacterial infections, hormonal imbalances, and sebum production. With increasing diagnosis and awareness of acne's systemic causes, dermatologists are more likely to prescribe oral treatments. Additionally, the demand for fast and long-term results is driving preference for oral therapies. The pharmaceutical industry's efforts to improve drug tolerability and reduce side effects have made oral acne medications more acceptable among patients. Furthermore, the rise in adult acne, particularly among women, has increased the prescription of oral hormonal therapies, expanding the overall market.

The growing prevalence of acne, especially among teenagers and young adults, is a key factor driving the acne medicine market. Hormonal changes, stress, dietary patterns, and environmental pollution contribute to acne outbreaks. As awareness of skin health increases, more individuals are actively seeking treatment options. This rising demand fuels product innovation and launches, encouraging manufacturers to develop both preventive and treatment-based medicines. Adult acne, particularly among working women, is also becoming a notable concern, pushing demand for specialized medications and dermatologist consultations. This demographic shift ensures a sustained need for effective acne therapies, thereby accelerating the overall market growth across both prescription and OTC segments.

Improved access to dermatology services and clinics is significantly influencing the acne medicine market. In both developed and developing economies, the number of dermatologists and specialized skincare centers is increasing. Government initiatives, insurance coverage, and urbanization are enhancing access to treatment. Additionally, teledermatology and online consultations have emerged as viable options for people in remote locations, further expanding the reach of acne treatments. The availability of professional guidance leads to increased prescriptions, higher treatment adherence, and more usage of both oral and topical medications. As healthcare infrastructure strengthens, especially in emerging markets, the demand for acne medicines continues to rise.

The rising emphasis on personal grooming and aesthetic appearance, particularly among younger populations, is boosting demand for acne solutions. Social media and digital influence are driving awareness about clear skin as a beauty standard, leading to increased spending on skincare products. Educational campaigns by brands, along with dermatologist-backed content, have contributed to de-stigmatizing acne while promoting proactive treatment. Consumers are becoming more knowledgeable about product ingredients and their effects, leading to demand for scientifically backed and dermatologically tested medicines. As people seek long-term solutions rather than quick fixes, the market is witnessing a surge in sustained usage of acne therapies.

There is a noticeable shift in consumer preferences toward natural and clean-label acne medications. Increasing awareness about the long-term impact of chemical-based products and concerns over skin sensitivity have pushed demand for safer, plant-based alternatives. Herbal formulations using tea tree oil, aloe vera, witch hazel, and green tea are becoming popular among eco-conscious consumers. Companies are responding by launching certified, cruelty-free, and non-toxic product lines, aligning with the values of sustainability and wellness. This trend is opening new growth avenues, especially in the premium segment, contributing to the diversification of the acne medicine market landscape.

Claim Yours Now! https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-13R16186&lic=single-user

ACNE MEDICINE MARKET SHARE:

Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share of about 50%.

North America is the largest market, with a share of about 50%, followed by Europe and Asia Pacific with the share of about 25% and 15%.North America leads due to high awareness, dermatologist availability, and product innovation. Asia-Pacific shows rapid growth driven by a large youth population, increasing urbanization, and rising income levels. Europe benefits from robust healthcare systems and increasing cosmetic concerns.

In terms of product, prescription medicine is the largest segment, with a share over 77%.

And in terms of application, the largest application is topical, followed by oral.

Key Companies:

  • Galderma
  • Galderma S A
  • Bausch Health
  • TEVA
  • GlaxoSmithKline PLC
  • Mylan NV
  • Almirall
  • Sun Pharma
  • Mayne Pharma
  • Lion
  • HUAPONT
  • Sine Pharma

Inquire for Discount: https://reports.valuates.com/request/discount/QYRE-Auto-13R16186/global-and-india-acne-medicine 

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

DISCOVER MORE INSIGHTS: EXPLORE SIMILAR REPORTS!

-          Acne Products Market
-          Baby Acne Medicine Market
-          The global Oral Acne Medicine market was valued at USD 929.9 Million in 2023 and is anticipated to reach USD 1144.1 Million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
-          Consumer Acne Medicine Market
-          The global market for Topical Acne Medication was estimated to be worth USD 2685.7 Million in 2023 and is forecast to a readjusted size of USD 4015.4 Million by 2030 with a CAGR of 6.0% during the forecast period 2024-2030
-          The global market for Acne Drugs was estimated to be worth USD 3616.6 Million in 2023 and is forecast to a readjusted size of USD 4592.8 Million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030.
-          LED Light Therapy Face Masks Market
-          Anti-acne Dermal Patch Market
-          Dissolvable Microneedle Patches market was valued at USD 485 Million in 2023 and is anticipated to reach USD 747 Million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
-          The global market for Cosmetics Microneedle Patches was valued at USD 472 Million in the year 2024 and is projected to reach a revised size of USD 748 Million by 2031, growing at a CAGR of 6.9% during the forecast period.
-          Moderate To Severe Acne Therapeutics Market

DISCOVER OUR VISION: VISIT ABOUT US!

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

GET A FREE QUOTE

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
WhatsApp: +91-9945648335

Website: https://reports.valuates.com
Blog: https://valuatestrends.blogspot.com/
Pinterest: https://in.pinterest.com/valuatesreports/
Twitter: https://twitter.com/valuatesreports
Facebook: https://www.facebook.com/valuatesreports/
YouTube: https://www.youtube.com/@valuatesreports6753

https://www.facebook.com/valuateskorean
https://www.facebook.com/valuatesspanish

https://www.facebook.com/valuatesjapanese

https://valuatesreportspanish.blogspot.com/

https://valuateskorean.blogspot.com/

https://valuatesgerman.blogspot.com/

https://valuatesreportjapanese.blogspot.com/
 

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

Modal title

Also from this source

Neurostimulation Devices Market to Reach USD 17.2 Billion by 2031 - Driven by Demand for Pain and Parkinson's Therapies | Valuates Reports

Neurostimulation Devices Market to Reach USD 17.2 Billion by 2031 - Driven by Demand for Pain and Parkinson's Therapies | Valuates Reports

Neurostimulation Devices Market is Segmented by Type (Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation...

Carbon Capture Utilization System Market Growth Fueled by Regulatory Pressure and Technological Advances | Valuates Reports

Carbon Capture Utilization System Market Growth Fueled by Regulatory Pressure and Technological Advances | Valuates Reports

Carbon Capture Utilization System (CCU) Market is Segmented by Type (Pre-Combustion Carbon Capture, Oxy-Combustion Carbon Capture, Post-Combustion...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.